1921
Volume 73, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Sexually transmitted infections are a serious health problem in Honduras. Human papillomavirus (HPV) and are major causes of sexually transmitted diseases. To determine the prevalence of and HPV in young women, 100 female university students in Honduras were assayed for the presence of these pathogens. Twenty-eight percent were positive for HPV and 6% were positive for . These results show that genital HPV and infections are very common among sexually active young women in Honduras. It is vital to promote extensive public awareness campaigns among sexually active women concerning preventive measures of these diseases.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2005.73.1.0730050
2005-07-01
2019-02-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/73/1/0730050.html?itemId=/content/journals/10.4269/ajtmh.2005.73.1.0730050&mimeType=html&fmt=ahah

References

  1. Ferlay J, Bray F, Pisani P, Parkin DM, 2001. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon: IARC Press, Version 1.0. IARC Cancer Base No.5.
  2. Koutsky L, 1997. Epidemiology of genital human papillomavirus infection. Am J Med 102: 3–8. [Google Scholar]
  3. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU, 2002. Proof of principle study investigators: a controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347: 1645–1651. [Google Scholar]
  4. Schiffman MH, 1992. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 84: 394–398. [Google Scholar]
  5. Barnes RC, 1989. Laboratory diagnosis of human chlamydial infections. Clin Microbiol Rev 3: 119–136. [Google Scholar]
  6. Center for Disease Control and Prevention, 1993. Recommendations for the prevention and management of Chlamydia trachomatis infections. MMWR Morbid Mortal Weekly Rep 42: 1–39. [Google Scholar]
  7. Boom R, Sol CJA, Salimans MM, Jansen CL, van Wetheim PME, van der Noordaa J, 1990. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28: 495–503. [Google Scholar]
  8. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N, 1985. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350–1354. [Google Scholar]
  9. Kleter B, van Doorn LJ, Schegget J, Schrauwen L, van Krimpen C, Burgear M, Harmsel B, Quint W, 1998. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 153: 1731–1739. [Google Scholar]
  10. Melchers WJ, Bakkers JM, Wang J, de Wilde PCM, Boonstra H, Quint WGV, 1999. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol 155: 1473–1478. [Google Scholar]
  11. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD, 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423–428. [Google Scholar]
  12. Fife KH, Cramer HM, Schroeder JM, Brown DR, 2001. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 64: 550–559. [Google Scholar]
  13. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ, 2000. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 87: 221–227. [Google Scholar]
  14. Ferrera A, Velema JP, Figueroa M, Bulnes R, Toro LA, Claros JM, Barahona O, Melchers WJG, 1999. Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study. Int J Cancer 82: 799–803. [Google Scholar]
  15. Schachter J, Hill EC, King EB, Heilbron DC, Ray RM, Margolis AJ, Greenwood SA, 1982. Chlamydia trachomatis and cervical neoplasia. JAMA 248: 2134–2138. [Google Scholar]
  16. Smith JS, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, Bosch FX, Walboomers JM, Peeling RW, 2002. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185: 324–331. [Google Scholar]
  17. Smith JS, Bosetti C, Munoz N, Herrero R, Bosch FX, Eluf-Neto J, Meijer CJ, van den Brule AJ, Franceschi S, Peeling RW, 2004. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 111: 431–439. [Google Scholar]
  18. Tamim H, Finan R, Sharida HE, Rashid M, Almawi WY, 2002. Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis 43: 277–281. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2005.73.1.0730050
Loading
/content/journals/10.4269/ajtmh.2005.73.1.0730050
Loading

Data & Media loading...

  • Received : 23 Sep 2004
  • Accepted : 19 Jan 2005

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error